EDSA (Edesa Biotech, Inc.) Short-Term Debt to Capital
Investment risks for Edesa Biotech, Inc. (EDSA) are driven by the potential failure of respiratory syndrome drug trials and a capital deficit. This chart illustrates the asset's market value on the GURU.Markets platform as 0.00. Edesa Biotech, Inc. (EDSA) develops advanced antibodies to combat severe immune pathologies, leveraging a robust scientific foundation, while outsourcing its manufacturing processes and medical research to third-party contractors.
Analytical breakdowns for Edesa Biotech, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Edesa Biotech, Inc.|EDSA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Edesa Biotech|EDSA - Aggregate Debt Obligations|Debts to Book Capitalization Edesa Biotech Inc|EDSA - Long-Term Debt Volume|Company Short-Term Debt Edesa Biotech|Quick Liquidity edesabiotech.com
- company profitability and valuation multiples indicators:
Fundamental valuation:Edesa
Focusing on the completion of Phase II/III clinical trials, Edesa Biotech, Inc. (EDSA) maintains a capital structure that minimizes urgent liabilities. An analysis of the current short-term debt to equity ratio allows for an assessment of the proportion of short-term loans to equity, which determines the company's level of dependence on external refinancing and confirms the stability of a financial base supported by investor confidence in management's scientific strategy.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|Current Liabilities to Capital Septerna Pharma|PVLA: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio SVRA|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital AnaptysBio Inc ANAB|Short-Term Debt to Equity Astria Pharma (ATXS)|Short-Term Debt to Capital Coefficient enGene Corp|Short-Term Debt to Capital RAPT (RAPT Therapeutics)|Short-Term Debt to Capital Aerovate Therapeutics, Inc. JBIO|ACRS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital KYTX (Kyverna Therapeutics Inc.)|TLSA: Short-Term Debt to Capital|CABA (Cabaletta Bio Inc) - Short-Term Debt to Equity|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|theratech.com (THTX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Avalo Therapeutics (AVTX)|ELDN - Current Liabilities to Capital|Agenus Inc - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio CLYM (Climb Bio, Inc)|Zura Bio - Short-Term Debt to Capital|Current Liabilities to Capital atyrpharma.com|ADAG: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Ikena Oncology|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|EQ: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio CNTB (Connect Biopharma)|IMUX (immunic-therapeutics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ATRA (Atara Bio)|Short-Term Debt to Capital Coefficient InflaRx NV (IFRX)|XFOR - Short-Term Debt to Equity|ACET (Adicet Bio) - Short-Term Debt to Capital Ratio|CELU: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio inmunebio.com|Short-Term Debt to Equity Ratio BRNS|Kezar Life Sciences Inc. (KZR) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital SABS|AKTX - Current Liabilities to Capital|Short-Term Debt to Capital ENLV (Enlivex Therapeutics Ltd.)|QTTB: Short-Term Debt to Capital Ratio|GOVX - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient iBio Inc IBIO|CARM: Short-Term Debt to Capital|XTL Bio (XTLB) - Short-Term Debt to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|HCW Biologics Inc - Current Liabilities to Equity|Short-Term Debt to Capital APVO|AIM (aimimmuno.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Debt to Capital GRI Bio Corporation GRI|XRTX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital HIND (reshapelifesciences.com)|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Indaptus Therapeutics Inc|SCNI (Scinai) - Short-Term Debt to Capital|Short-Term Debt to Capital CalciMedica Corp|Short-Term Debt to Equity Ratio AFMD (Affimed)|ALLK (allakos.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital Coefficient IGM Biosciences Inc. (IGMS)|ITOS - Short-Term Debt to Equity|Ocean Biomedical Corp (OCEA) - Short-Term Debt to Equity Ratio|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com